Holdco Nuvo Group DG (NUVO)

Profile

Full Name

Holdco Nuvo Group D.G Ltd

Ticker Symbol

NUVO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

Israel

IPO

Indexes

Not included

Website

http://www.nuvocares.com

Employees

-

Key Details

Price

$0.00(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$176.00K

Annual EPS

-$1.01(-62.75% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.00
NUVO price is $0.00

30-Day Relative Volume

3.08
NUVO 30-day relative volume is 3.08

Price Performance

Price Most recent change

0%
NUVO {parameterFullLabel} has remained unchanged on Apr 11, 2025

Price YTD change

-70%
NUVO price is down -70% since January 1st

Price 1-year change

-
NUVO price 1-year change is unknown

Price 3-year change

-
NUVO price 3-year change is unknown

Price Range

Price All-time high

$8.25
NUVO price is currently -99.99% below its historical high of $8.25

Price 3-year low

$0.00
NUVO price is currently +800.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$29.94K
NUVO market capitalization is $29.94 thousand

Market cap 3-year change

-
NUVO market capitalization 3-year change is unknown

Market cap All-time high

$174.62M
NUVO market capitalization is currently -99.98% below its historical high of $174.62 million

Market cap sector rank

1.97%
NUVO market capitalization is higher than 1.97% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.41%
NUVO shares outstanding is up +0.41% year-on-year

Shares Outstanding 3-Year Change

-
NUVO shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-18.00
NUVO beta is -18.00

200-day SMA

$0.18
NUVO price is currently -99.49% below its 200-day simple moving average

50-day SMA

$0.00
NUVO price is currently -35.71% below its 50-day simple moving average

RSI

50.00
NUVO 14-day relative strength index is 50.00

Volume

3.08
NUVO 30-day relative volume is 3.08

ATR

$0.00
NUVO average true range is $0.00

10-day Historical Volatility

0.00%
NUVO 10-day historical volatility is 0.00%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$176.00K
NUVO annual revenue is $176.00 thousand

Revenue Analysts estimate

-
NUVO annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
NUVO annual revenue 1-year change is unknown

Revenue Sector rank

6.72%
NUVO annual revenue is higher than 6.72% of companies in Healthcare sector

EPS

EPS

-$1.01
NUVO annual earnings per share is -$1.01

EPS Analysts estimate

-
NUVO annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-62.75%
NUVO annual earnings per share is down -62.75% year-on-year

EPS Sector rank

56.48%
NUVO annual earnings per share is higher than 56.48% of companies in Healthcare sector

Profit

Gross profit

-$15.00K
NUVO annual gross profit is -$15.00 thousand

Gross margin

-8.52%
NUVO annual gross profit margin is -8.52%

Operating profit

-$16.63M
NUVO annual operating income is -$16.63 million

Operating margin

-9450.57%
NUVO annual operating profit margin is -9450.57%

Net income

-$33.66M
NUVO annual net profit is -$33.66 million

Net margin

-19.12K%
NUVO annual net profit margin is -19.12 thousand%

Expenses

Total expenses

$16.81M
NUVO annual total expenses is $16.81 million

Operating expenses

$16.62M
NUVO annual total operating expenses is $16.62 million

Cost of goods sold

$191.00K
NUVO annual cost of goods sold is $191.00 thousand

Selling, general & administrative expenses

$8.29M
NUVO annual SGA is $8.29 million

Depreciation and amortization

$206.00K
NUVO annual depreciation & amortization is $206.00 thousand

Interest expense

$44.00K
NUVO annual interest expense is $44.00 thousand

Income tax

-$1.04M
NUVO annual income tax is -$1.04 million

EBIT & EBITDA

EBIT

-$34.65M
NUVO annual earnings before interest & taxes is -$34.65 million

EBITDA

-$34.44M
NUVO annual EBITDA is -$34.44 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.49M
NUVO annual total assets is $3.49 million

Non current assets

$1.91M
NUVO annual long term assets is $1.91 million

Current assets

$1.58M
NUVO annual total current assets is $1.58 million

Cash and cash equivalents

$553.00K
NUVO annual cash & cash equivalents is $553.00 thousand

Accounts receivable

$40.00K
NUVO annual accounts receivable is $40.00 thousand

Inventory

$20.00K
NUVO annual inventory is $20.00 thousand

Liabilities

Total liabilities

$70.98M
NUVO annual total liabilities is $70.98 million

Long term liabilities

$40.03M
NUVO annual total long term liabilities is $40.03 million

Current liabilities

$30.95M
NUVO annual total current liabilities is $30.95 million

Accounts payable

$952.00K
NUVO annual accounts payable is $952.00 thousand

Debt

Total debt

$11.58M
NUVO annual total debt is $11.58 million

Total debt 1-year change

+27.08%
NUVO annual total debt is up +27.08% year-on-year

Long term debt

$949.00K
NUVO annual long term debt is $949.00 thousand

Short term debt

$10.63M
NUVO annual short term debt is $10.63 million

Equity & Capital

Shareholders equity

-$67.49M
NUVO annual stockholders equity is -$67.49 million

Book value

-$67.49M
NUVO annual book value is -$67.49 million

Retained earnings

-$143.77M
NUVO annual retained earnings is -$143.77 million

Working capital

-$29.37M
NUVO annual working capital is -$29.37 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$14.96M
NUVO annual cash flow from operations is -$14.96 million

Cash from operations 1-year change

-11.02%
NUVO annual cash flow from operations is down -11.02% year-on-year

Cash from investing

-$38.00K
NUVO annual cash flow from investing activities is -$38.00 thousand

Cash from investing 1-year change

+86.28%
NUVO annual cash flow from investing activities is up +86.28% year-on-year

Cash from financing

$14.44M
NUVO annual cash flow from financing activities is $14.44 million

Cash from financing 1-year change

+47.01%
NUVO annual cash flow from financing activities is up +47.01% year-on-year

CAPEX

CAPEX

$38.00K
NUVO annual capital expenditures is $38.00 thousand

CAPEX 1-year change

-
NUVO annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$14.99M
NUVO annual free cash flow is -$14.99 million

Free cash flow 1-year change

-9.25%
NUVO annual free cash flow is down -9.25% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-8.52%
NUVO annual gross profit margin is -8.52%

Operating margin

-9450.57%
NUVO annual operating profit margin is -9450.57%

Net margin

-19.12K%
NUVO annual net profit margin is -19.12 thousand%

ROA & ROE

ROA

-965.43%
NUVO annual return on assets is -965.43%

ROE

49.87%
NUVO annual return on equity is 49.87%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NUVO price to earnings ratio value is unknown

PE ratio Sector rank

-
NUVO price to earnings ratio is unknown

PB Ratio

PB ratio

0.00
NUVO price to book ratio is 0.00

PB ratio Sector rank

16.61%
NUVO price to book ratio is higher than 16.61% of companies in Healthcare sector

PS Ratio

PS ratio

-
NUVO price to sales ratio value is unknown

PS ratio Sector rank

-
NUVO price to sales ratio is unknown

Enterprise value

Enterprise value

$11.05M
NUVO enterprise value is $11.05 million

Enterprise value Sector rank

26.13%
NUVO enterprise value is higher than 26.13% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
NUVO EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
NUVO EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.05
NUVO annual current ratio is 0.05

Quick ratio

0.05
NUVO annual quick ratio is 0.05

Leverage

Debt to equity

-0.17
NUVO annual debt to equity ratio is -0.17

Interest coverage ratio

-787.50
NUVO annual interest coverage ratio is -787.50

Risk & Stability

Piotroski F-Score

-
NUVO piotroski f-score value is unknown

Altman Z-Score

-100.60
NUVO altman z-score is -100.60

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

VAXX logo
Vaxxinity (VAXX)
PXMD logo
PaxMedica (PXMD)
NVOS logo
Novo Integrated Sciences (NVOS)
SCPS logo
Scopus BioPharma (SCPS)
BTTX logo
Better Therapeutics (BTTX)
EVLO logo
Evelo Biosciences (EVLO)
CMRA logo
Comera Life Sciences Holdings (CMRA)
NMRD logo
Nemaura Medical (NMRD)
STAB logo
Statera Biopharma (STAB)
  • What is the ticker symbol for Holdco Nuvo Group DG?
  • Does Holdco Nuvo Group DG pay dividends?
  • What sector is Holdco Nuvo Group DG in?
  • What industry is Holdco Nuvo Group DG in?
  • What country is Holdco Nuvo Group DG based in?
  • Is Holdco Nuvo Group DG in the S&P 500?
  • Is Holdco Nuvo Group DG in the NASDAQ 100?
  • Is Holdco Nuvo Group DG in the Dow Jones?
  • When was Holdco Nuvo Group DG's last earnings report?
  • When does Holdco Nuvo Group DG report earnings?

What is the ticker symbol for Holdco Nuvo Group DG?

The ticker symbol for Holdco Nuvo Group DG is NASDAQ:NUVO

Does Holdco Nuvo Group DG pay dividends?

No, Holdco Nuvo Group DG does not pay dividends

What sector is Holdco Nuvo Group DG in?

Holdco Nuvo Group DG is in the Healthcare sector

What industry is Holdco Nuvo Group DG in?

Holdco Nuvo Group DG is in the Medical Devices industry

What country is Holdco Nuvo Group DG based in?

Holdco Nuvo Group DG is headquartered in Israel

Is Holdco Nuvo Group DG in the S&P 500?

No, Holdco Nuvo Group DG is not included in the S&P 500 index

Is Holdco Nuvo Group DG in the NASDAQ 100?

No, Holdco Nuvo Group DG is not included in the NASDAQ 100 index

Is Holdco Nuvo Group DG in the Dow Jones?

No, Holdco Nuvo Group DG is not included in the Dow Jones index

When was Holdco Nuvo Group DG's last earnings report?

Holdco Nuvo Group DG's most recent earnings report was on Nov 29, 2024

When does Holdco Nuvo Group DG report earnings?

The date for Holdco Nuvo Group DG's next earnings report has not been announced yet
On this page